375 mg Trastuzumab Injection

Get a Price/Quote

MOQ : 100 Packs

375 mg Trastuzumab Injection Specification

Indication
HER2-positive breast cancer, HER2-positive gastric cancer

Dosage Form
Injection

Salt Composition
Trastuzumab 375 mg

Enzyme Types
Not an enzyme, monoclonal antibody

Feature
Lyophilized single-use vial, preservative-free

Ingredients
Trastuzumab, excipients, sterile water for injection

Application
Cancer therapy

Ph Level
Neutral (typically pH 6.0 for reconstituted solution)

Physical Color/Texture
White to pale yellow lyophilized powder

Fermentation Smell
Odorless

Enzymatic Activity
Not applicable; therapeutic monoclonal antibody

Storage Instructions
Store at 2C to 8C (refrigerated), protect from light

Shelf Life
24 months from manufacturing date

Container Type
Single-use glass vial

Stability After Reconstitution
Stable for 24 hours at 2C to 8C

Packaging Size
1 vial per pack

Manufacturer Information
Available upon request from respective supplier

Diluent
Sterile water for injection (as per instructions)

Brand Availability
May vary according to manufacturer

Route of Administration
Intravenous infusion only

Prescription Status
Prescription only

Reconstitution Volume
7.2 mL for a 375 mg vial

Contraindications
Hypersensitivity to trastuzumab or any excipients

Adverse Effects
Infusion reactions, cardiac toxicity, pulmonary toxicity

Market Authorization
Approved by regulatory agencies for oncology use

Precautions
Administer under supervision of qualified healthcare professional

Compatibility
Do not mix with other medicinal products except those recommended

Strength
375 mg/vial

375 mg Trastuzumab Injection Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About 375 mg Trastuzumab Injection

Discover a crowning solution in oncology care with the 375 mg Trastuzumab Injection, presented as a blue-ribbon, single-use glass vial. This magnificent advance purchase offers exceptional value for HER2-positive breast and gastric cancer therapy. Approved by regulatory authorities and renowned for its stability and efficacy, this hot deal is ideal for hospital or clinical use. The lyophilized powder reconstitutes to a neutral pH and must be administered via intravenous infusion. Each vial is odorless, preservative-free, and delivers unwavering quality, ensuring safety with every dose.

Application Features and Uses

The 375 mg Trastuzumab Injection is intended for intravenous application, using sterile water for injection as the reconstitution media. Used as a targeted therapy, this monoclonal antibody is prescribed specifically for HER2-positive breast and gastric cancer patients. The powder is administered under medical supervision, ensuring precision and optimum results. Its neutral pH and preservative-free formulation further uphold patient safety. The surface of application is strictly via the intravenous route, adhering to oncology administration protocols.

Domestic Market Reach and Packaging

This product is widely available across the Indian domestic market, supplied through trusted distributors and traders. The supply ability supports immediate pharmacy needs, and each packaging contains one glass vial per box for single use. The list price and asking price for the 375 mg Trastuzumab Injection may vary depending on brand availability and supplier selection, ensuring value while upholding stringent packaging standards to maintain product stability and quality throughout its shelf life.

FAQ's of 375 mg Trastuzumab Injection:

Q: How should the 375 mg Trastuzumab Injection be administered?

A: This injection is administered as an intravenous infusion only, following reconstitution with sterile water for injection and under direct supervision of a qualified healthcare professional.

Q: What is the main indication for using Trastuzumab 375 mg Injection?

A: Trastuzumab 375 mg Injection is primarily indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric cancer, as prescribed by your oncologist.

Q: Where should the reconstituted Trastuzumab Injection be stored?

A: After reconstitution, the prepared solution should be stored at 2C to 8C and protected from light. It remains stable for 24 hours under these conditions.

Q: What is the process for preparing the 375 mg Trastuzumab Injection for use?

A: Reconstitute the lyophilized powder with 7.2 mL of sterile water for injection as instructed. Ensure the solution is clear before administering and do not mix with unapproved products.

Q: What are the safety precautions when using Trastuzumab Injection?

A: The medication must be used only under medical supervision, ensuring patients are monitored for potential infusion reactions, cardiac, or pulmonary toxicity. Contraindicated in those with hypersensitivity to trastuzumab or its excipients.

Tell us about your requirement